Swift Medical raises $35M to break silence around wound care technology | 2021-08-06
TORONTO – A “silent epidemic” all but “ignored” by medical technology developers. That’s how Carlo Perez, founder and CEO of Swift Medical Inc., described the hesitancy of the industry to directly tackle chronic wound care through development of more advanced medical imaging and diagnostic systems. Undaunted, U.S. and Canadian investors have raised $35 million in series B funding to advance development and uptake of Swift Medical’s own AI-powered, digital wound care platform.
BioWorld MedTech Financings Series B Diagnostics Artificial intelligence Digital health Mobile/smartphone app Canada
Gloss